Loading organizations...
§ Private Profile · Bonneuil-sur-marne, France
Manufactures eco-engineered, biodegradable microcapsules for industrial use in agriculture, consumer care, advanced materials.
Calyxia is a Limeil-Brévannes, France-based manufacturer that designs and produces biodegradable microcapsules and microspheres to protect and deliver active ingredients for industrial applications. The company provides business-to-business solutions as sustainable alternatives to traditional microplastics across the agriculture, consumer care, and advanced materials sectors, supplying top agrochemical companies that cover 80 percent of the global market. Following its recent B Corp certification, the enterprise secured $50 million in Series B funding in 2024 to finance global expansion and open a second industrial site designed to accommodate up to 300 employees. Operating as an academic spin-off, the firm leverages scientific research originating from ESPCI Paris-PSL and Harvard University, while receiving financial backing from venture capital firms including Astanor Ventures and the European Investment Fund. Calyxia was founded in 2015 by co-founder and chief executive officer Jamie Walters.
Calyxia has raised $53.0M across 2 funding rounds.
Calyxia has raised $53.0M in total across 2 funding rounds.
Calyxia is a French deep-tech industrial startup that designs, manufactures, and sells high-performance, eco-engineered microcapsules and microspheres for global manufacturers in agriculture, consumer care, and advanced materials.[1][2][3] These tiny containers protect and deliver active chemical ingredients on demand, solving environmental challenges like microplastic pollution by offering biodegradable alternatives that reduce impact on natural resources and biodiversity while maintaining performance.[1][2][4] Serving major agrochemical companies covering 80% of the global market, Calyxia enables precision agriculture, sustainable chemistry, and regulation-compliant solutions at no extra cost, with strong growth including $50 million in Series B funding in 2024, B Corp certification, and expansion to 100+ employees.[3][4][6]
Calyxia emerged in 2015 as a spin-off from ESPCI-PARIS PSL and Harvard University, leveraging over 30 years of emulsion science advancements.[1][3] Co-founded by CEO Jamie Walters, the team of scientists, engineers, and industry experts developed a patented microencapsulation platform to address industrial and environmental challenges like pollution and biodiversity loss.[3][4] Key milestones include inauguration of its first facility in 2016 by French President François Hollande and Paris Mayor Anne Hidalgo, first investment in 2017, establishment of its initial industrial site in 2018, and a 2023 i-demo R&D grant from the French government under France 2030, alongside starting Series B funding and breaking ground on a second site.[3] By 2024, it secured $50 million (€31.5 million) in Series B from international investors like Astanor Ventures (EIF-backed), achieved B Corp status in May, and reached 100 employees; 2025 saw the opening of its second industrial site and new headquarters in Limeil-Brévannes for 300 employees.[2][3][4][6]
Calyxia rides the wave of sustainable chemistry and circular economy trends, directly tackling the global microplastic crisis amid tightening regulations on non-biodegradable plastics in agriculture and consumer goods.[2][4] Its timing aligns with rising demand for eco-friendly alternatives in precision agriculture—enhancing food production without environmental harm—and EU initiatives like France 2030, which supported its scaling via grants and funding.[3][5] Market forces favoring it include agrochemical giants seeking compliant, cost-neutral solutions covering 80% of global markets, plus B Corp validation signaling credibility in impact investing.[2][4] By partnering with distributors like Brenntag and investors like Astanor, Calyxia influences the ecosystem, pushing chemical industries toward biodegradability and lower resource use, potentially transforming value chains over 20-30 years.[1][4]
Calyxia's new 2025 headquarters and second site position it for hyper-scaling production to serve a global client base, building on Series B momentum and Brenntag partnership.[1][3] Trends like stricter microplastic bans, precision agtech adoption, and sustainable materials demand will propel growth, with its biodegradable tech enabling mass-market shifts in chemicals.[2][4][5] Its influence may evolve from innovator to industry standard-setter, amplifying impact through expanded operations in France, Germany, Japan, and the US, while inspiring similar deep-tech sustainability plays.[2][3] This spin-off turned multinational exemplifies how academic roots can drive industrial environmental breakthroughs.
Calyxia has raised $53.0M in total across 2 funding rounds.
Calyxia's investors include Cindy Ung Delouis, Lombard Odier Investment Managers, Astanor Ventures, Target Global.
Calyxia has raised $53.0M across 2 funding rounds. Most recently, it raised $35.0M Series B in September 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2024 | $35M Series B | Cindy UNG Delouis, Lombard Odier Investment Managers | Astanor Ventures, Target Global | Announced |
| Sep 1, 2021 | $18M Series A | Astanor Ventures | Target Global | Announced |